Range Cancer Therapeutics ETF Stock Price, News & Analysis
CNCR
NASDAQ
Company Description
Range Cancer Therapeutics ETF (NASDAQ: CNCR) is a publicly traded company.
CNCR stock has declined 37.4% over the past year. Shares last traded at $9.32.
This page provides a comprehensive overview of CNCR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
$—
0.00%
0.00
Last updated:
-37.36%
Performance 1 year
$0.0
780.0K
Range Cancer Therapeutics ETF (CNCR) stock last traded at $9.32. Over the past 12 months, the stock has lost 37.4%.
Latest News
Range Cancer Therapeutics ETF has 1 recent news article. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. View all CNCR news →
SEC Filings
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Operating Cash Flow
Upcoming Events
Short Interest History
Last 12 Months
Days to Cover History
Last 12 Months
Frequently Asked Questions
What is the current stock price of Range Cancer Therapeutics ETF (CNCR)?
The current stock price of Range Cancer Therapeutics ETF (CNCR) is $9.32 as of May 27, 2025.